Special Edition
 Life Science Nation Newsletter  | January 4, 2018   |  Issue 247

Life Science
Investor Mandates
(Dec. 28 - Jan. 3 )
By Nono Hu, Director of Marketing, LSN

JPM week is almost upon us, and at Life Science Nation, we're making the final preparations for RESI San Francisco. It's our largest event of the year; if you want to join over a thousand life science executives and investors for targeted one-on-one meetings, you've got 5 more days to sign up. In the meantime, please check out the RESI Program Guide below to see all our RESI Innovators, sponsors, exhibitors and speakers. With attendees from all over the world coming to RESI to make new connections and continue compelling dialogues, RESI San Francisco is the most focused event next week for early stage companies and investors. We'll look forward to seeing you all face to face next week.

Created & Produced by
Life Science
Investor Mandates
(Dec. 28 - Jan. 3 )
Seeking Early-Stage In-Licensing Opps in NASH and Immuno-oncology
Invests in Making Acquisitions and Distribution Agreements in the Medical Device Sector in Worldwide
Manages Angel Funds with Broad Interest in Life Sciences, Including Pre-Clinical Assets
Invests in Medical Devices and Healthcare IT Companies, With Particular Interest in AI and Machine Learning Applications
Invests Opportunistically with Strong Interest in AI-Driven Medical Devices
Invests Broadly in All Life Sciences Companies with European Angle
Seeks Therapeutics and Medical Technologies with Strong Clinical Data
Invests Up to $20M in Therapeutics, Medtech, and Digital Health Companies With Strong Clinical Data
Seeking Healthtech Companies with Low Regulatory Hurdles
Provides Multiple Grant Programs to Support Early-Stage Companies in Alzheimer's Disease and Dementia
Invests in Medtech and Digital Health Companies with Focus in Underserved Regions of USA
Makes Angel Investments in All Sectors of Life Sciences from Seed to Series A
Seeks Medical Devices, IVD Tools, Healthcare IoT Technologies
Seeks Later-Stage Life Science Investment Opportunities
Focuses on Medical Device Company Creation and Investments Across USA, Europe, and Israel
Actively Seeking Early-Stage Investment Opportunities in All Sectors and Indications of Life Sciences
Focuses on Therapeutics, Medical Device, and Healthcare IT Companies in the USA
Invests in Early-Stage Data-Driven Technologies in Life Sciences
Focuses Exclusively in Life Science Companies that Address Neurological and Psychiatric Disease Therapeutics
Seeks Digital Health Investment Opportunities Globally